Eli Lilly is trading 3.08% up now at $1150.03 as investors focus on the Morgan Stanley Global Healthcare Conference scheduled for September 14, 2026.
- The presentation is drawing renewed institutional attention to GLP-1 commercial momentum and the company’s pipeline.
- Foundayo prescriptions rose 8% to approximately 47,500, reinforcing confidence in the oral weight-loss franchise.
- Healthcare is outperforming broader markets, though the specific company catalyst appears stronger than general market sentiment.